A growing body of evidence suggests a margin safety for TRT in hypogonadal men with treated PCa. Several studies have demonstrated symptomatic improvement in hypogonadism without the development of ...

This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...

CHICAGO—Metastasis-free survival or overall survival may be a more reliable and meaningful clinical endpoint than PSA relapse in studies of prostate cancer (PCa) patients treated with androgen ...

Over a mean follow-up of 33 months, those who used topical 1.62% testosterone gel had a 0.19% incidence of high-grade prostate cancer (Gleason score ≥4 + 3), similar to the 0.12% among placebo-treated ...

Clinical markers of successful liquid biopsy-based genomic profiling in veterans with prostate cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...

SAN ANTONIO -- More than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed biochemical recurrence after receiving postoperative apalutamide (Erleada) and androgen ...